BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned.
Hayne, Dickon
BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned. [electronic resource] - BJU international 05 2017 - 55-57 p. digital
Publication Type: Letter; Meta-Analysis; Research Support, Non-U.S. Gov't; Review
1464-410X
10.1111/bju.13873 doi
Administration, Intravesical
Australia
BCG Vaccine--administration & dosage
Clinical Trials, Phase III as Topic
Disease-Free Survival
Female
Humans
Male
Mitomycin--administration & dosage
Neoplasm Invasiveness--pathology
Neoplasm Staging
Prognosis
Randomized Controlled Trials as Topic
Risk Assessment
Survival Analysis
Treatment Outcome
Urinary Bladder Neoplasms--drug therapy
BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned. [electronic resource] - BJU international 05 2017 - 55-57 p. digital
Publication Type: Letter; Meta-Analysis; Research Support, Non-U.S. Gov't; Review
1464-410X
10.1111/bju.13873 doi
Administration, Intravesical
Australia
BCG Vaccine--administration & dosage
Clinical Trials, Phase III as Topic
Disease-Free Survival
Female
Humans
Male
Mitomycin--administration & dosage
Neoplasm Invasiveness--pathology
Neoplasm Staging
Prognosis
Randomized Controlled Trials as Topic
Risk Assessment
Survival Analysis
Treatment Outcome
Urinary Bladder Neoplasms--drug therapy